P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.

MLA

Clementine Sarkozy, et al. “P1079: Very Long-Term Follow-Up of Rituximab Maintenance in Young Patients with Mantle Cell Lymphoma Included in the Lyma Trial, a Lysa Study.” HemaSphere, vol. 7, Aug. 2023. EBSCOhost, https://doi.org/10.1097/01.HS9.0000971212.06197.a0.

APA

Clementine Sarkozy, Catherine Thieblemont, Lucie Oberic, Anne Moreau, Kamal Bouabdallah, Gandhi Laurent Damaj, Thomas Gastinne, Vincent Ribrag, Rene Olivier Casasnovas, Corinne Haioun, Roch Houot, Fabrice Jardin, Eric Van Den Neste, Morgane Cheminant, Franck Morschhauser, Mary Callanan, Herve Ghesquieres, Remy Gressin, Olivier Hermine, & Steven Le Gouill. (2023). P1079: Very Long-Term Follow-Up of Rituximab Maintenance in Young Patients with Mantle Cell Lymphoma Included in the Lyma Trial, a Lysa Study. HemaSphere, 7. https://doi.org/10.1097/01.HS9.0000971212.06197.a0

Chicago

Clementine Sarkozy, Catherine Thieblemont, Lucie Oberic, Anne Moreau, Kamal Bouabdallah, Gandhi Laurent Damaj, Thomas Gastinne, et al. 2023. “P1079: Very Long-Term Follow-Up of Rituximab Maintenance in Young Patients with Mantle Cell Lymphoma Included in the Lyma Trial, a Lysa Study.” HemaSphere 7 (August). doi:10.1097/01.HS9.0000971212.06197.a0.